Correlation Between Genovate Biotechnology and Johnson Health

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Genovate Biotechnology and Johnson Health at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Genovate Biotechnology and Johnson Health into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Genovate Biotechnology Co and Johnson Health Tech, you can compare the effects of market volatilities on Genovate Biotechnology and Johnson Health and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Genovate Biotechnology with a short position of Johnson Health. Check out your portfolio center. Please also check ongoing floating volatility patterns of Genovate Biotechnology and Johnson Health.

Diversification Opportunities for Genovate Biotechnology and Johnson Health

0.27
  Correlation Coefficient

Modest diversification

The 3 months correlation between Genovate and Johnson is 0.27. Overlapping area represents the amount of risk that can be diversified away by holding Genovate Biotechnology Co and Johnson Health Tech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Johnson Health Tech and Genovate Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Genovate Biotechnology Co are associated (or correlated) with Johnson Health. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Johnson Health Tech has no effect on the direction of Genovate Biotechnology i.e., Genovate Biotechnology and Johnson Health go up and down completely randomly.

Pair Corralation between Genovate Biotechnology and Johnson Health

Assuming the 90 days trading horizon Genovate Biotechnology is expected to generate 3.82 times less return on investment than Johnson Health. In addition to that, Genovate Biotechnology is 2.26 times more volatile than Johnson Health Tech. It trades about 0.01 of its total potential returns per unit of risk. Johnson Health Tech is currently generating about 0.1 per unit of volatility. If you would invest  6,610  in Johnson Health Tech on September 2, 2024 and sell it today you would earn a total of  9,140  from holding Johnson Health Tech or generate 138.28% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy99.73%
ValuesDaily Returns

Genovate Biotechnology Co  vs.  Johnson Health Tech

 Performance 
       Timeline  
Genovate Biotechnology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Genovate Biotechnology Co has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, Genovate Biotechnology is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.
Johnson Health Tech 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Johnson Health Tech are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Johnson Health showed solid returns over the last few months and may actually be approaching a breakup point.

Genovate Biotechnology and Johnson Health Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Genovate Biotechnology and Johnson Health

The main advantage of trading using opposite Genovate Biotechnology and Johnson Health positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Genovate Biotechnology position performs unexpectedly, Johnson Health can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Johnson Health will offset losses from the drop in Johnson Health's long position.
The idea behind Genovate Biotechnology Co and Johnson Health Tech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.

Other Complementary Tools

Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities